Lilly Asia Ventures (LAV) is a leading biomedical venture capital firm headquartered in China, with offices in Shanghai, Hong Kong, and Palo Alto.
Investment Type: Venture Capital
Mentions in press and media 5
| Date | Title | Description | Category | Author | Source |
| 10.05.2021 | Alebund Ph... | SHANGHAI, May 10, 2021 /PRNews... | - | - | en.prnasia... |
| 26.07.2016 | Gates Foun... | Just Biotherapeutics CEO and F... | - | Nat Levy | geekwire.c... |
| 06.01.2016 | Daily fund... | Flatiron Health bagged $175M; ... | - | Mitos Suso... | vator.tv/n... |
| 29.10.2015 | MabSpace B... | MabSpace Biosciences Co., Ltd.... | China | - | finsmes.co... |
| 21.09.2015 | Daily fund... | Deciphera bagged $75M; Portea ... | - | Mitos Suso... | vator.tv/n... |